L-NMMA's Effect on Renal and Cardiovascular Variables in Healthy Subjects. A Randomized, Placebo-controlled Crossover Study.

Trial Profile

L-NMMA's Effect on Renal and Cardiovascular Variables in Healthy Subjects. A Randomized, Placebo-controlled Crossover Study.

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Feb 2011

At a glance

  • Drugs Tilarginine (Primary)
  • Indications Cardiogenic shock; Myocardial infarction
  • Focus Pharmacodynamics
  • Most Recent Events

    • 24 Jun 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Feb 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top